M 66 (Meloxicam 7.5 mg)
Pill imprint M 66 has been identified as Meloxicam 7.5 mg.
Meloxicam is used in the treatment of osteoarthritis; inflammatory conditions; rheumatoid arthritis; fibromyalgia; tendonitis (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. Prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. Starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Meloxicam 7.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- M 66
- 7.5 mg
- 6.00 mm
- Prescription only
- Drug Class:
- Nonsteroidal anti-inflammatory agents
- Pregnancy Category:
- C - Risk cannot be ruled out - prior to 30 weeks gestation
D - Positive evidence of risk - starting at 30 weeks gestation
- CSA Schedule:
- Not a controlled drug
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
sodium lauryl sulfate
Note: Inactive ingredients may vary.
|NDC Code||Manufacturer / Repackager|
|51079-0457||UDL Laboratories Inc|
More about meloxicam
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 309 Reviews – Add your own review/rating
- Drug class: nonsteroidal anti-inflammatory agents
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.